Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate versus atomoxetine versus combination therapy in children with ADHD
IRCT20190526043708N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate and atomoxetine, sponsored by Mashhad University of Medical Sciences. Started Jul 2018; status: completed.
02
Drugs
methylphenidateatomoxetine
Beyond the preview
Go deeper on IRCT20190526043708N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190526043708N1.